PRODUCT DESCRIPTION
The GB CL CA19-9 is an in vitro diagnostic quantitative chemiluminescent reagent kit designed for measuring carbohydrate antigen 19-9 (CA19-9) in human serum or plasma.
It applies a sandwich chemiluminescent immunoassay (CLIA) with magnetic microparticles, requiring only 10 µL of sample and providing results in 10 minutes. The limit of quantification (LoQ) is 1.80 U/mL, allowing rapid and reliable quantitation. Reagents must be stored at 2–8°C, protected from direct sunlight, and not frozen.
CA19-9 is an important tumor marker widely used as a tool in the diagnosis and monitoring of gastrointestinal cancers, particularly pancreatic, bile duct, gastric, and colorectal cancers.